Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:322-329, doi:10.1016/j.jacc.2006.03.036 (Published online 22 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Videos
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nusser, T.
Right arrow Articles by Wöhrle, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nusser, T.
Right arrow Articles by Wöhrle, J.

Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiography in Patients With Transcatheter Closure of Patent Foramen Ovale

Thorsten Nusser, MD1, Martin Höher, MD, FESC, Nico Merkle, MD, Olaf C. Grebe, MD, Jochen Spiess, MD, Hans A. Kestler, PhD, Volker Rasche, PhD, Matthias Kochs, MD, Vinzenz Hombach, MD* and Jochen Wöhrle, MD, FESC1

Department of Internal Medicine II–Cardiology, University of Ulm, Ulm, Germany.


Figure 1
View larger version (149K):

[in a new window]
 
Figure 1 The time intensity curves of the same patient as in Figure 2 during a contrast-enhanced cardiac magnetic resonance imaging study while performing a Valsalva maneuver. The blue line represents the signal intensity in the right atrium, and the red line denotes the signal increase in the left atrium. The blue line shows its maximal peak earlier than the red line because of the earlier contrast enhancement of right versus left atrium after intravenously administered contrast agent. The black arrow indicates the contrast passage over the patent foramen ovale showing an additional smaller peak before the maximal peak in the left atrium.

 

Figure 2
View larger version (147K):

[in a new window]
 
Figure 2 A series of steady-state free-precession sequences in a patient with patent foramen ovale and atrial septal aneurysm. (A) A four-chamber view and (B) a short-axis view before interventional closure. The two arrows indicate the separated atrial septum. The same patient at 12-month follow-up after transcatheter closure in (C) a four-chamber view and (D) a short-axis view. The arrows point at the closure device (for cine sequences, see Online ).

 

Figure 3
View larger version (32K):

[in a new window]
 
Figure 3 This plot shows the grade of provocable right-to-left shunting over patent foramen ovale (PFO) in 75 patients assessed by transesophageal echocardiography (TEE) before transcatheter closure, after device implantation, and at follow-up.

 

Figure 4
View larger version (125K):

[in a new window]
 
Figure 4 A new structure next to the right atrium was seen on cardiac magnetic resonance imaging 3 months after interventional closure of a patent foramen ovale. (A) Four-chamber view steady-state free precession sequence, (B) proton-weighted coronal turbo spin echo. After 25 months the supposed hematoma had completely disappeared, which is shown in (C) and (D), images acquired by a T2-weighted black-blood technique.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement